The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Mrs Khadija Sami
    Born in March 1982
    Individual (4 offsprings)
    Person with significant control
    2020-08-04 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 2
    Abdullah, Suhaib
    Pharmacist born in January 1975
    Individual (29 offsprings)
    Officer
    2023-06-06 ~ now
    OF - director → CIF 0
  • 3
    Unit 18, Neills Road, Bold, St. Helens, England
    Corporate (5 parents, 29 offsprings)
    Person with significant control
    2024-08-04 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 1
  • Sami, Khadija
    Nutritional Therapist born in March 1982
    Individual (4 offsprings)
    Officer
    2020-08-04 ~ 2023-06-06
    OF - director → CIF 0
parent relation
Company in focus

CORE PHARMACEUTICALS LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Property, Plant & Equipment
9,604 GBP2023-08-31
0 GBP2022-08-31
Debtors
1,443 GBP2023-08-31
3,000 GBP2022-08-31
Cash at bank and in hand
4,068 GBP2023-08-31
160 GBP2022-08-31
Current Assets
5,511 GBP2023-08-31
3,160 GBP2022-08-31
Creditors
Current, Amounts falling due within one year
-20,064 GBP2023-08-31
-1,456 GBP2022-08-31
Net Current Assets/Liabilities
-14,553 GBP2023-08-31
1,704 GBP2022-08-31
Total Assets Less Current Liabilities
-4,949 GBP2023-08-31
1,704 GBP2022-08-31
Creditors
Non-current, Amounts falling due after one year
-10,210 GBP2023-08-31
0 GBP2022-08-31
Net Assets/Liabilities
-15,159 GBP2023-08-31
1,704 GBP2022-08-31
Equity
Called up share capital
100 GBP2023-08-31
100 GBP2022-08-31
Retained earnings (accumulated losses)
-15,259 GBP2023-08-31
1,604 GBP2022-08-31
Equity
-15,159 GBP2023-08-31
1,704 GBP2022-08-31
Average Number of Employees
12022-09-01 ~ 2023-08-31
12021-09-01 ~ 2022-08-31
Property, Plant & Equipment - Gross Cost
Other
10,062 GBP2023-08-31
0 GBP2022-08-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
458 GBP2023-08-31
0 GBP2022-08-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
458 GBP2022-09-01 ~ 2023-08-31
Property, Plant & Equipment
Other
9,604 GBP2023-08-31
0 GBP2022-08-31

  • CORE PHARMACEUTICALS LIMITED
    Info
    Registered number 12792227
    Unit 18 Unit 18, Bold Industrial Park, Neills Road, St Helens WA9 4TU
    Private Limited Company incorporated on 2020-08-04 (4 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-11
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.